Molecular obesity therapies advance, but precision prescribing remains largely unproven
A 2026 review finds that multi-agonist obesity drugs can produce substantial weight loss, but biomarker and pharmacogenomic tools are not ...
Tag: obesity pharmacotherapy
POPULAR NEWS
-
Molecular obesity therapies advance, but precision prescribing remains largely unproven
-
Expert Interviews Shape Human Insider Threat Framework in Three Sectors
-
Communicating neuropsychological assessment results: a qualitative study in Dutch memory clinic professionals
-
Treated Wastewater Alters Spinach Soil Chemistry and Microbes in Greenhouse Study